← Leaderboards
Ari J Green
University Of California, San Francisco
$2,473,192
Attributed
$3,109,083
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $645.4K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,109,083 · 2
By mechanism
R01$3,109,083 · 2
Top collaborators
- Jeremy William Gordon2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jonathan C Horton$13,501,495
- Jennifer Rose-Nussbaumer$10,499,043
- Satya Dandekar$23,346,836
- Sabrina Miriam Ronen$18,398,578
- Diane V Havlir$125,216,731
Others in their field
Other Emerging Leaders on “Multiple Sclerosis Patient”
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- Gary Fanger · Rise Therapeutics, Llc$9,656,247
- Hemali Phatnani · New York University School Of Medicine$7,892,246
- Ansuman Satpathy · Stanford University$7,721,054
- Julio Cesar Rojas-Martinez · University Of California, San Francisco$7,570,303
- James Dale Berry · Brigham And Women'S Hospital$6,359,203
Research focus
Multiple Sclerosis PatientDisease RemissionMultiple Sclerosis LesionsPre-ClinicalLesionImmunomodulatory TherapiesInflammatoryMultiple SclerosisReproducibilityTemporal MeasurementMagnetic Resonance ImagingBiological MarkersInflammationBrainDrug ScreeningDemyelinationsDisabilityElectron MicroscopyClinical DevelopmentAblationClinicClinical InvestigationAnteriorChronic Demyelination
Grant awards (7)
MR Metabolic Imaging of Multiple Sclerosis$626,409
R01 · FY2024 · NS
MR Metabolic Imaging of Multiple Sclerosis$645,373
R01 · FY2023 · NS
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function$367,392
R01 · FY2022 · NS · contact PI
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function$364,510
R01 · FY2021 · NS · contact PI
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function$364,206
R01 · FY2020 · NS · contact PI
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function$362,544
R01 · FY2019 · NS · contact PI
Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function$378,649
R01 · FY2018 · NS · contact PI